Avory & Company’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Sell
66,730
-10,407
-13% -$420K 3.46% 8
2026
Q1
$2.57M Sell
77,137
-156,571
-67% -$6.55M 3.33% 9
2025
Q4
$10.6M Sell
233,708
-8,853
-4% -$324K 6.78% 6
2025
Q3
$7.39M Sell
242,561
-1,313
-0.5% -$40.4K 4.45% 8
2025
Q2
$7.17M Buy
243,874
+2,317
+1% +$69.3K 4.37% 7
2025
Q1
$8.44M Buy
241,557
+351
+0.1% +$13.9K 5.58% 7
2024
Q4
$10.7M Sell
241,206
-12,926
-5% -$581K 6.02% 6
2024
Q3
$11.1M Buy
254,132
+3,703
+1% +$140K 6.72% 6
2024
Q2
$6.78M Buy
250,429
+9,466
+4% +$274K 4.77% 10
2024
Q1
$7.04M Buy
240,963
+47,801
+25% +$1.45M 4.8% 10
2023
Q4
$7.27M Buy
193,162
+39,386
+26% +$1.45M 5.09% 9
2023
Q3
$6.93M Buy
153,776
+28,416
+23% +$1.72M 5.88% 9
2023
Q2
$9.24M Sell
125,360
-28,348
-18% -$1.91M 7.03% 9
2023
Q1
$9.02M Buy
153,708
+86,915
+130% +$4.79M 6.2% 10
2022
Q4
$3.37M Buy
66,793
+12,545
+23% +$753K 2.71% 11
2022
Q3
$4.72M Sell
54,248
-11,949
-18% -$1.26M 4% 10
2022
Q2
$7.53M Sell
66,197
-911
-1% -$105K 6.39% 9
2022
Q1
$8.69M Buy
67,108
+21,139
+46% +$3.05M 5.44% 8
2021
Q4
$6.96M Sell
45,969
-46,006
-50% -$7.98M 4.18% 9
2021
Q3
$13.7M Sell
91,975
-1,639
-2% -$251K 8.43% 7
2021
Q2
$14.2M Sell
93,614
-25,254
-21% -$3.52M 7.88% 6
2021
Q1
$15.4M Sell
118,868
-43,666
-27% -$5.6M 8.89% 7
2020
Q4
$19.5M Buy
+162,534
New +$15.9M 13.11% 2

Other funds holding OMCL

Avory & Company's OMCL Position: Q2 2026 in Review

Avory & Company reduced its Omnicell (OMCL) stake by 13% in Q2 2026, selling an estimated $420K and leaving 66,730 shares worth $2.77M. The position accounts for 3.46% of the portfolio, ranked #8.

Avory & Company first reported a position in OMCL in Q4 2020 and has held it in 23 quarters since. The position peaked at $19.5M in Q4 2020. 304 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Avory & Company held 66,730 shares of Omnicell worth $2.77M as of Q2 2026.
  • Avory & Company sold 10,407 Omnicell shares in Q2 2026, an estimated $420K.
  • Omnicell made up 3.46% of Avory & Company's portfolio in Q2 2026, its #8 holding.
  • Avory & Company first reported a position in Omnicell in Q4 2020 and has held it in 23 quarters since.
  • Avory & Company's Omnicell position peaked at $19.5M in Q4 2020.
  • 304 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Avory & Company's 13F filing for Q2 2026, filed 23 Jul 2026.